<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">dengue </span>
   <span class="font23">al.: </span>
   <span class="font20">DENV </span>
   <span class="font16">Dengue </span>
   <span class="font16">vaccine </span>
   <span class="font16">virus </span>
   <span class="font15">infections </span>
   <span class="font15">infection </span>
   <span class="font14">disease </span>
   <span class="font14">Recommendation </span>
   <span class="font13">children </span>
   <span class="font13">severe </span>
   <span class="font12">Trop </span>
   <span class="font12">vascular </span>
   <span class="font12">Infect </span>
   <span class="font12">Dis.;():–. </span>
   <span class="font12">clinical </span>
   <span class="font12">protection </span>
   <span class="font12">heterotypic </span>
   <span class="font12">human </span>
   <span class="font12">{border-style </span>
   <span class="font12">antibodies </span>
   <span class="font12">second </span>
   <span class="font12">px;} </span>
   <span class="font12">years </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">tetravalent </span>
   <span class="font11">cells </span>
   <span class="font11">responses </span>
   <span class="font11">Med </span>
   <span class="font11">permeability </span>
   <span class="font11">protein </span>
   <span class="font11">endothelial </span>
   <span class="font11">risk </span>
   <span class="font11">./journal.pntd. </span>
   <span class="font11">Dis.;():e. </span>
   <span class="font11">Negl </span>
   <span class="font11">Virus </span>
   <span class="font11">fever </span>
   <span class="font11">Aedes </span>
   <span class="font11">DENVs </span>
   <span class="font11">type </span>
   <span class="font11">phase </span>
   <span class="font11">shock </span>
   <span class="font11">viruses </span>
   <span class="font11">efficacy </span>
   <span class="font11">high </span>
   <span class="font11">highly </span>
   <span class="font11">humans </span>
   <span class="font11">severity </span>
   <span class="font11">./S-()- </span>
   <span class="font11">Zika </span>
   <span class="font11">age </span>
   <span class="font11">attenuated </span>
   <span class="font11">cases </span>
   <span class="font11">dose </span>
   <span class="font11">evidence </span>
   <span class="font11">hemorrhagic </span>
   <span class="font11">live </span>
   <span class="font11">mice </span>
   <span class="font11">observed </span>
   <span class="font11">single </span>
   <span class="font10">Asia </span>
   <span class="font10">Hyg.;():–. </span>
   <span class="font10">Vaccine </span>
   <span class="font10">antibody </span>
   <span class="font10">cell </span>
   <span class="font10">data </span>
   <span class="font10">enhanced </span>
   <span class="font10">features </span>
   <span class="font10">genetic </span>
   <span class="font10">immune </span>
   <span class="font10">non-structural </span>
   <span class="font10">patients </span>
   <span class="font10">platelet </span>
   <span class="font10">px; </span>
   <span class="font10">secondary </span>
   <span class="font10">{font-family </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dengvaxia </span>
   <span class="font10">Human </span>
   <span class="font10">T-cell </span>
   <span class="font10">Virol.;():–. </span>
   <span class="font10">adults </span>
   <span class="font10">bleeding </span>
   <span class="font10">cycle </span>
   <span class="font10">different </span>
   <span class="font10">epidemiology, </span>
   <span class="font10">font-size </span>
   <span class="font10">immunity </span>
   <span class="font10">live-attenuated </span>
   <span class="font10">pii: </span>
   <span class="font10">primary </span>
   <span class="font10">seronegative </span>
   <span class="font10">syndrome </span>
   <span class="font10">viral </span>
   <span class="font10">./journal.ppat. </span>
   <span class="font10">Antibody </span>
   <span class="font10">DVPS </span>
   <span class="font10">GII </span>
   <span class="font10">Health </span>
   <span class="font10">Pathog.;():e. </span>
   <span class="font10">Sci </span>
   <span class="font10">Vietnamese </span>
   <span class="font10">aegypti </span>
   <span class="font10">antibodies, </span>
   <span class="font10">associated </span>
   <span class="font10">controlled </span>
   <span class="font10">double; </span>
   <span class="font10">inapparent </span>
   <span class="font10">interval </span>
   <span class="font10">neutralizing </span>
   <span class="font10">occur </span>
   <span class="font10">old </span>
   <span class="font10">older </span>
   <span class="font10">outcome </span>
   <span class="font10">prospective </span>
   <span class="font10">protected </span>
   <span class="font10">proteins </span>
   <span class="font10">raised </span>
   <span class="font10">strain </span>
   <span class="font10">studies </span>
   <span class="font10">time </span>
   <span class="font10">transmission </span>
   <span class="font10">trials </span>
   <span class="font10">./JVI.- </span>
   <span class="font10">./pnas. </span>
   <span class="font10">Acad </span>
   <span class="font10">Cell </span>
   <span class="font10">HalsteadSB: </span>
   <span class="font10">Med.;():–. </span>
   <span class="font10">Natl </span>
   <span class="font10">Neutralizing </span>
   <span class="font10">Responses </span>
   <span class="font10">antibody-dependent </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">circulating </span>
   <span class="font10">contribute </span>
   <span class="font10">correlate </span>
   <span class="font10">correlated </span>
   <span class="font10">cytokines </span>
   <span class="font10">dengue-immune </span>
   <span class="font10">dengue: </span>
   <span class="font10">did </span>
   <span class="font10">differences </span>
   <span class="font10">directed </span>
   <span class="font10">early </span>
   <span class="font10">enhancement </span>
   <span class="font10">epidemiological </span>
   <span class="font10">evolution </span>
   <span class="font10">greater </span>
   <span class="font10">higher </span>
   <span class="font10">infected </span>
   <span class="font10">infections, </span>
   <span class="font10">infectious </span>
   <span class="font10">leakage </span>
   <span class="font10">nonstructural </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">persons </span>
   <span class="font10">populations </span>
   <span class="font10">protective </span>
   <span class="font10">related </span>
   <span class="font10">role </span>
   <span class="font10">serotype </span>
   <span class="font10">solid; </span>
   <span class="font10">study </span>
   <span class="font10">transfusion </span>
   <span class="font10">visited </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">./ajtmh.- </span>
   <span class="font10">./fimmu.. </span>
   <span class="font10">./s--- </span>
   <span class="font10">American </span>
   <span class="font10">Antibodies </span>
   <span class="font10">Bangladesh </span>
   <span class="font10">Clin </span>
   <span class="font10">DENV, </span>
   <span class="font10">Disease </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Epidemiology </span>
   <span class="font10">Faculty </span>
   <span class="font10">Genetic </span>
   <span class="font10">Immunol.;:. </span>
   <span class="font10">Infection </span>
   <span class="font10">LATV </span>
   <span class="font10">National </span>
   <span class="font10">Prophylactic </span>
   <span class="font10">Protective </span>
   <span class="font10">Safety </span>
   <span class="font10">Studies </span>
   <span class="font10">Tetravalent </span>
   <span class="font10">Thailand, </span>
   <span class="font10">ability </span>
   <span class="font10">absence </span>
   <span class="font10">acquired </span>
   <span class="font10">acute </span>
   <span class="font10">antibodies. </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">cause </span>
   <span class="font10">city </span>
   <span class="font10">cohort </span>
   <span class="font10">collab: </span>
   <span class="font10">counts </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokine </span>
   <span class="font10">demonstrated </span>
   <span class="font10">develop </span>
   <span class="font10">developed </span>
   <span class="font10">em; </span>
   <span class="font10">epidemic </span>
   <span class="font10">factors </span>
   <span class="font10">final </span>
   <span class="font10">following </span>
   <span class="font10">frequency </span>
   <span class="font10">frequently </span>
   <span class="font10">global </span>
   <span class="font10">groups </span>
   <span class="font10">hemophagocytic </span>
   <span class="font10">home </span>
   <span class="font10">levels </span>
   <span class="font10">locations </span>
   <span class="font10">long </span>
   <span class="font10">low </span>
   <span class="font10">members </span>
   <span class="font10">mosquito </span>
   <span class="font10">onset </span>
   <span class="font10">outcomes </span>
   <span class="font10">passively </span>
   <span class="font10">pathophysiological </span>
   <span class="font10">platelets </span>
   <span class="font10">presence </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomised, </span>
   <span class="font10">research </span>
   <span class="font10">result </span>
   <span class="font10">review </span>
   <span class="font10">sera </span>
   <span class="font10">silent </span>
   <span class="font10">solid </span>
   <span class="font10">spent </span>
   <span class="font10">strongly </span>
   <span class="font10">successfully </span>
   <span class="font10">symptomatic </span>
   <span class="font10">symptoms </span>
   <span class="font10">syndrome: </span>
   <span class="font10">urban </span>
   <span class="font10">used </span>
   <span class="font10">vaccinated </span>
   <span class="font10">vector </span>
   <span class="font10">virus, </span>
   <span class="font10">vivo </span>
   <span class="font10">yellow </span>
  </p>
 </body>
</html>
